ImmunoGen, Inc. IMGN
31.24 0.00 (+0.00%)
Feb 9, 2024, 3:58 PM EST
31.22 Day range 31.25
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 108.78M | 69.86M | 132.30M | 82.27M | 53.45M | |
| 108.61M | 69.86M | 132.30M | 82.27M | 53.45M | |
| -220.89M | -125.07M | -22.38M | -92.17M | -161.45M | |
| -222.93M | -139.30M | -44.37M | -104.13M | -168.84M | |
| -0.88 | -0.68 | -0.25 | -0.70 | -1.21 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 275.14M | 478.75M | 293.86M | 176.22M | 262.25M | |
| 348.94M | 525.76M | 355.07M | 235.26M | 295.38M | |
| 193.11M | 200.18M | 265.50M | 311.38M | 284.41M | |
| 15.24M | 18.78M | 23.89M | 26.85M | 2.06M | |
| 155.83M | 325.59M | 89.57M | -76.12M | 10.97M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -229.80M | -169.42M | -78.62M | -88.37M | -166.42M | |
| -1.36M | -1.43M | 509.00K | -533.00K | -5.25M | |
| 27.55M | 355.74M | 195.74M | 2.87M | 166.81M | |
| -1.36M | -1.43M | 509.00K | -533.00K | -5.25M | |
| -203.61M | 184.89M | 117.63M | -86.03M | -4.86M |